EGRX
Eagle Pharmaceuticals, Inc.
EGRX
EGRX
Delisted
EGRX was delisted on the 2nd of October, 2024.
116 hedge funds and large institutions have $667M invested in Eagle Pharmaceuticals, Inc. in 2016 Q2 according to their latest regulatory filings, with 24 funds opening new positions, 45 increasing their positions, 28 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
8% less first-time investments, than exits
New positions opened: 24 | Existing positions closed: 26
3% less funds holding
Funds holding: 119 → 116 (-3)
Holders
116
Holding in Top 10
5
Calls
$11.6M
Puts
$7.55M
Top Buyers
| 1 | +$40.2M | |
| 2 | +$26.8M | |
| 3 | +$21.3M | |
| 4 |
HEC
Hudson Executive Capital
New York
|
+$20.5M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$8.99M |
Top Sellers
| 1 | -$32.7M | |
| 2 | -$9.11M | |
| 3 | -$8.22M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
-$7.31M |
| 5 |
State Street
Boston,
Massachusetts
|
-$6.73M |